Physician profile
Liam P Ryan
NPI 1487845509
$17,300.74
in general payments reported to CMS, 2019-2025
9 companies · $2,217 in 2025
The $2,217 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $119 · 2021: $12.60 · 2022: $1,782 · 2023: $2,041 · 2024: $925 · 2025: $2,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $830 · Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $830.36 |
| Food and Beverage | $252.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $12,391.45 | 2019-2025 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $2,505.66 | 2022-2024 | Gore Bio-A Tissue Reinforcement, Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $2,168.96 | 2021-2023 | Valiant Captivia, Endurant Iis |
| Abbott Laboratories | $144.47 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.26 | 2025 | Lifevest |
| Supreme Orthopedic Systems, LLC | $19.92 | 2025 | |
| Veryan Medical Incorporated | $18.90 | 2022 | |
| Angiodynamics, INC. | $18.12 | 2023 | Angiovac |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liam Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.